McGrath D, Uy J, Yang R, et al. Efficacy and safety by racial group in ARV-naive subjects treated with atazanavir/ritonavir or lopinavir/ritonavir: 48-week results for the CASTLE study (AI424138). Program and abstracts of the 17th International AIDS Conference; August 3-8, 2008; Mexico City, Mexico. Abstract TUPE0058.